Oncology · Gastrointestinal Malignancy
The facts most likely to be tested
Hematochezia and tenesmus are the most common clinical presentations of rectal cancer, often leading to a misdiagnosis of hemorrhoids.
Digital rectal exam (DRE) is the mandatory initial physical exam step to palpate for a rectal mass or ulcerated lesion.
Flexible sigmoidoscopy or colonoscopy with biopsy is the gold standard for definitive tissue diagnosis.
Endorectal ultrasound (ERUS) or pelvic MRI is the preferred modality for local staging to determine the depth of invasion and involvement of the mesorectal fascia.
Carcinoembryonic antigen (CEA) levels are used primarily for post-treatment surveillance and monitoring for recurrence rather than initial screening.
Neoadjuvant chemoradiation followed by total mesorectal excision (TME) is the standard of care for locally advanced (T3/T4 or node-positive) rectal cancer.
Lynch syndrome (HNPCC) is the most common hereditary cause of rectal cancer, necessitating microsatellite instability (MSI) testing on all resected specimens.
Vignette unlocked
A 58-year-old male presents with a 3-month history of bright red blood per rectum and a persistent sensation of incomplete evacuation. He reports a recent change in bowel habits with narrowing of stool caliber. Physical examination reveals a palpable, firm, fixed mass at 5 cm from the anal verge on digital rectal exam. Laboratory studies show a mild iron deficiency anemia.
What is the most appropriate next step in the management of this patient?
Pelvic MRI
The patient has a clinically suspected rectal cancer; after biopsy confirmation, pelvic MRI is the essential next step for local staging to guide the decision between primary surgery and neoadjuvant chemoradiation.
Full handout
High yield triage
Etiology / Epidemiology
Associated with Lynch syndrome and Familial Adenomatous Polyposis (FAP). Primary risk factors include age >50, high-fat/low-fiber diet, and ulcerative colitis.
Clinical Manifestations
Presents with tenesmus, hematochezia, and pencil-thin stools. Digital rectal exam may reveal a palpable mass.
Diagnosis
Colonoscopy with biopsy is the gold standard. CEA levels are used for post-treatment surveillance.
Treatment
Localized disease requires Total Mesorectal Excision (TME). Neoadjuvant 5-Fluorouracil plus radiation is standard for stage II/III.
Prognosis
Prognosis is determined by TNM staging. Liver metastasis is the most common site of distant spread.
Full handout
Epidemiology & Etiology
Incidence peaks in the 6th and 7th decades of life. Genetic predisposition via Lynch syndrome (HNPCC) accounts for 3-5% of cases. Chronic inflammation from ulcerative colitis significantly increases malignant transformation risk.
Pertinent Anatomy
The rectum is defined as the distal 15 cm of the large bowel. The lack of a serosal layer in the rectum facilitates direct invasion into adjacent pelvic structures.
Pathophysiology
The adenoma-carcinoma sequence involves sequential mutations in APC, KRAS, and p53 tumor suppressor genes. Microsatellite instability (MSI) is a hallmark of hereditary cases. Chronic mucosal irritation leads to dysplasia, then invasive adenocarcinoma.
Clinical Manifestations
Patients often report hematochezia or occult blood loss leading to iron deficiency anemia. Tenesmus and a sensation of incomplete evacuation are highly suggestive. Red flags include unexplained weight loss, bowel habit changes, and obstruction.
Diagnosis
Colonoscopy with biopsy is mandatory for tissue diagnosis. Endorectal ultrasound or pelvic MRI is required for local staging of the depth of invasion. CEA (carcinoembryonic antigen) is a non-diagnostic marker used for monitoring recurrence.
Treatment
Surgical Total Mesorectal Excision (TME) is the cornerstone of curative therapy. Neoadjuvant 5-Fluorouracil (5-FU) or capecitabine combined with radiation is indicated for stage II/III disease. Contraindications to sphincter-sparing surgery include tumors involving the anal sphincter complex.
Prognosis
Survival is heavily dependent on the depth of invasion and nodal involvement. CEA levels should be monitored every 3-6 months for 2 years post-resection. Liver metastasis is the most common cause of mortality.
Differential Diagnosis
Hemorrhoids: bright red blood without bowel habit change
Anal Fissure: severe pain with defecation
Diverticulitis: left lower quadrant pain with fever
Inflammatory Bowel Disease: chronic diarrhea with mucus
Rectal Prolapse: visible protrusion of rectal mucosa